Curis competitors

Curis's competitors include Harpoon Therapeutics, Aptevo Therapeutics, Oncternal Therapeutics and Geron Corporation
Add company...
Curis
Curis is a biotechnology company focused on the development and commercialization of innovative and effective drug candidates for the treatment of human cancers.
Harpoon Therapeutics
Harpoon Therapeutics is a preclinical stage biotechnology company.
Aptevo Therapeutics
Aptevo Therapeutics is a biotech company primarily focused on bringing novel oncology and hematology therapeutics to market.
Oncternal Therapeutics
Oncternal Therapeutics is a clinical-stage oncology company developing first-in-class and novel therapies for both rare and common cancers.
Geron Corporation
Geron is a clinical stage biopharmaceutical company focused on the development of a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies.
Founding Date
Founding Date
2000
Founding Date
2015
Founding Date
2016
Founding Date
2013
Founding Date
1990
Type
Type
Public
Type
Private
Type
Public
Type
Private
Type
Public
Tags
Locations
Locations
Lexington, US HQ
Locations
South San Francisco, US HQ
Locations
Seattle, US HQ
Locations
San Diego, US HQ
Locations
Menlo Park, US HQ
Canton, US
Employees
Employees
58
Employees
33
Employees
118
Employees
N/A
Employees
15
Valuation ($)
Valuation ($)
53.8 m
Valuation ($)
N/A
Valuation ($)
115.8 m
Valuation ($)
N/A
Valuation ($)
1 b

Financial

Revenue (est.)
Revenue (est.)
$9.9m (FY, 2017)
Revenue (est.)
N/A
Revenue (est.)
$14.7m (FY, 2017)
Revenue (est.)
N/A
Revenue (est.)
$1.1m (FY, 2017)
Net income
Net income
($53.3m) (FY, 2017)
Net income
N/A
Net income
$7m (FY, 2017)
Net income
N/A
Net income
($27.9m) (FY, 2017)

Funding

Latest funding round
Latest funding round
N/A
Latest funding round
$ 45m (over 1 year ago)
Latest funding round
N/A
Latest funding round
$ 18.4m (over 1 year ago)
Latest funding round
N/A
Total funding raised
Total funding raised
N/A
Total funding raised
$ 60m
Total funding raised
N/A
Total funding raised
$ 18.6m
Total funding raised
$ 96.7m
For sources of this data, please see the company profileDownload Excel

View company profiles

Harpoon Therapeutics
HQ
South San Francisco, US
Employees
33

Harpoon Therapeutics is a preclinical stage biotechnology company.

View company
Aptevo Therapeutics
HQ
Seattle, US
Employees
118

Aptevo Therapeutics is a biotech company primarily focused on bringing novel oncology and hematology therapeutics to market.

View company
Oncternal Therapeutics
HQ
San Diego, US

Oncternal Therapeutics is a clinical-stage oncology company developing first-in-class and novel therapies for both rare and common cancers.

View company
Geron Corporation
HQ
Menlo Park, US
Employees
15

Geron is a clinical stage biopharmaceutical company focused on the development of a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies.

View company